Cipla News: Read Latest News & Live Updates on Cipla, Photos, Videos at CNBCTV18.com

homeCipla News

Cipla NEWS

All

market | Apr 24, 2024 6:03 PM IST
Here's why Cipla stock rallied over 3% on Wednesday
business | Apr 15, 2024 10:23 PM IST
Cipla arm Cipla Health to buy Ivia Beaute's cosmetics, personal care business for ₹130 crore
market | Apr 12, 2024 1:53 PM IST
Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth
market | Apr 10, 2024 9:11 AM IST
Cipla Patalganga Unit: CNBC-TV18 accesses the six USFDA observations
market | Apr 5, 2024 8:01 AM IST
Cipla's Patalganga facility gets a form 483 with six observations from USFDA
healthcare | Mar 3, 2024 11:24 AM IST
Maker of spurious antibiotics busted in Uttarakhand, big pharma companies exploited
market | Jan 27, 2024 1:10 PM IST
Samina Hamied stepping down as Cipla VC not part of any stake sale plan: Exclusive
healthcare | Jan 25, 2024 9:00 AM IST
India may consider restricting fluoroquinolone antibiotics just like the UK did
market | Jan 23, 2024 1:35 PM IST
Cipla shares rise 8% to hit 52-week high on robust Q3 earnings
photos | Jan 23, 2024 4:59 AM IST
Stocks To Watch: Zee Entertainment, ICICI Bank, Cipla, IDFC First Bank, Tata Motors and more
earnings | Jan 22, 2024 8:19 PM IST
Cipla Q3 results: Pharma major records highest ever revenue and EBITDA margin
business | Jan 20, 2024 10:35 PM IST
Cipla reschedules board meeting amid social media leak
healthcare | Jan 15, 2024 10:38 PM IST
Pharma Q3FY24 outlook: What the Street anticipates
business | Jan 8, 2024 7:48 PM IST
Cipla partners with Kemwell and Manipal for innovative cell therapy products worldwide
healthcare | Nov 28, 2023 12:58 PM IST
Cipla share price: The market is afraid about risks that don't exist, says Bernstein

Cipla NEWS

Here's why Cipla stock rallied over 3% on Wednesday

Cipla arm Cipla Health to buy Ivia Beaute's cosmetics, personal care business for ₹130 crore

Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth

Cipla Patalganga Unit: CNBC-TV18 accesses the six USFDA observations

Cipla's Patalganga facility gets a form 483 with six observations from USFDA

Maker of spurious antibiotics busted in Uttarakhand, big pharma companies exploited

Samina Hamied stepping down as Cipla VC not part of any stake sale plan: Exclusive

India may consider restricting fluoroquinolone antibiotics just like the UK did

Cipla shares rise 8% to hit 52-week high on robust Q3 earnings

Stocks To Watch: Zee Entertainment, ICICI Bank, Cipla, IDFC First Bank, Tata Motors and more

Cipla Q3 results: Pharma major records highest ever revenue and EBITDA margin

Cipla reschedules board meeting amid social media leak

Pharma Q3FY24 outlook: What the Street anticipates

Cipla partners with Kemwell and Manipal for innovative cell therapy products worldwide

Cipla share price: The market is afraid about risks that don't exist, says Bernstein